Longitude reports 8.6% stake in Rapid Micro Biosystems
Rapid Micro Biosystems, Inc. Schedule 13G/A Amendment No. 2 discloses that certain Longitude entities and two affiliated individuals report shared beneficial ownership of 3,529,245 shares of Class A common stock, representing 8.6% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Rapid Micro Biosystems, Inc. Schedule 13G/A Amendment No. 2 discloses that certain Longitude entities and two affiliated individuals report shared beneficial ownership of 3,529,245 shares of Class A common stock, representing 8.6% of the class. The filing cites March 31, 2026 as the share count reference, with 41,267,511 shares outstanding reported in the issuer's proxy statement.
The reporting persons named include Longitude Capital Partners II, LLC, Longitude Venture Partners II, L.P., and individuals Patrick G. Enright and Juliet Tammenoms Bakker. The filing states these shares are held of record by LVPII and that LCPII, as general partner, and the two managing members may be deemed to share voting and dispositive power.
Insights
Institutional holders disclose shared control over an 8.6% stake reported as of March 31, 2026.
The filing lists 3,529,245 shares held of record by LVPII with shared voting and dispositive power attributed to LCPII and its managing members. This is a standard ownership disclosure under Schedule 13G/A attributing beneficial ownership across affiliated entities and individuals.
Key dependencies include the issuer's outstanding share count of 41,267,511 used to calculate 8.6%. Subsequent filings could update percentages if outstanding shares or holdings change; timing is tied to the March 31, 2026 reference in the proxy statement.
Report clarifies record ownership and attribution among fund, general partner, and managers.
The filing explains that LVPII holds the shares of record while LCPII, as general partner, and Messrs. Enright and Bakker may be deemed to share voting and dispositive power. The report includes the standard disclaimer of direct beneficial ownership by the reporting individuals except to the extent of any pecuniary interest.
Investor implications are factual: the excerpt quantifies holdings (3,529,245 shares) and the as of date anchor. Further changes will appear only in later amendments or separate filings.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficial ownership financial
held of record regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Longitude report in Rapid Micro Biosystems (RPID)?
Who are the named reporting persons in the 13G/A?
What date is used to compute the 8.6% ownership figure?
Does the filing indicate any change in holdings or transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.